1. Characteristics and Outcomes of Parotid Gland Tumors in Adolescents.
- Author
-
Kanetake, Hirofumi, Inaka, Yuko, Kinoshita, Ichita, Ayani, Yusuke, Ozaki, Akiko, Omura, Shuji, Higashino, Masaaki, Terada, Tetsuya, Haginomori, Shin-ichi, and Kawata, Ryo
- Subjects
- *
CYTOLOGY , *SYMPTOMS , *TUMOR grading , *DESCRIPTIVE statistics , *ADENOMA , *NEEDLE biopsy , *PROGRESSION-free survival , *ADOLESCENCE ,PAROTID gland tumors - Abstract
Objective: Parotid tumors are rare neoplasms in adults but are exceedingly infrequent in adolescents. We aimed to determine the clinical characteristics and outcomes of parotid tumors in adolescents under 20 years old. Methods: Between 1999 and 2020, 979 cases of benign parotid tumors and 236 cases of malignant parotid tumors were treated surgically in our department. Of these, 12 benign cases (1.2%) and 9 malignant cases (3.8%) were in adolescents. There were no benign or malignant cases for those aged under 10 years. Results: Regarding the histological type, all benign tumors were pleomorphic adenomas. About half of malignant tumors were mucoepidermoid carcinomas, and excluding one high-grade case, the grade of malignancy was all low/intermediate. The accuracy of fine-needle aspiration cytology among adolescents showed no significant difference with that of adults. In contrast to adults, adolescent benign tumor cases showed a markedly high rate of pleomorphic adenomas and no postoperative facial nerve palsy. Malignant tumors in adolescents had a different trend than adults; low/intermediate-grade malignancies were common and thus few symptoms/signs of malignancy could be observed. As well, the accuracy of fine-needle aspiration cytology was poor. All cases had a good prognosis and are disease-free survival. Conclusion: Parotid tumors in adolescents are rare but have several characteristics that are distinct from adults. As long-term observation is required posttreatment in adolescent patients, recurrence in benign pleomorphic adenomas and poor long-term prognosis in malignant tumors, especially for those with low/intermediate-grade malignancy, are more likely to be observed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF